NASDAQ
MODD
Last Price
US $1.87
Valuation
Financial
Performance
Cash flow to debt coverage
Modular Medical, Inc. cash flow to debt ratio of -6.04K% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.
Free cash flow growth
Modular Medical, Inc.'s free cash flow has decreased 52.01% from $-18.21M last year to $-27.68M, signaling decreasing performance
Debt-to-equity ratio
Modular Medical, Inc.'s debt to equity ratio is 0.03, which means that the company's assets are healthy financed, signaling financial stability.
Debt-to-equity trend
Modular Medical, Inc.'s debt has decreased relative to shareholder equity from 0.05 last year to 0.03 today, signaling strengthened financials
Net debt to EBITDA
Modular Medical, Inc. has a net cash position, so leverage is healthy.
Interest coverage
Interest expense is not separately reported in Modular Medical, Inc.'s latest filing, so interest coverage cannot be calculated.
Profit margin growth
Modular Medical, Inc. has insufficient data to evaluate this check.
Current ratio
Modular Medical, Inc.'s short-term assets of $7.54M exceed its short-term liabilities of $1.87M
Return on assets
Modular Medical, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization
Return on equity
Modular Medical, Inc.'s return on equity of -286.34%, is lower than 15.00%, indicating bad performance
Earnings quality
Modular Medical, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation
Earnings stability
Modular Medical, Inc. has insufficient public price history to evaluate earnings stability.
Positive free cash flow
Modular Medical, Inc. has negative free cash flow, indicating the company is burning cash rather than generating it
Free cash flow yield
Modular Medical, Inc. has negative free cash flow, indicating cash burn
Earnings growth
Modular Medical, Inc.'s yearly earnings has decreased 50.03% since last year from $-18.82M to $-28.24M, signaling decreasing performance
Revenue growth
Modular Medical, Inc.'s yearly revenue has increased 0.00% since last year from $0.00 to $0.00, signaling increasing performance
Return on invested capital
ROIC -206.41% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.
3-year revenue CAGR
Modular Medical, Inc. has insufficient revenue history to calculate 3-year revenue CAGR.
Revenue consistency
Modular Medical, Inc. had revenue growth in 5 out of 5 years, indicating consistent revenue performance
Return on equity consistency
Modular Medical, Inc. has insufficient public price history to evaluate ROE consistency.
Cash Flow Valuation (DCF)
Modular Medical, Inc. has insufficient data to evaluate this check.
Earnings yield (TTM)
Modular Medical, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
EBITDA Valuation
Modular Medical, Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model
EV/EBITDA (FY)
Modular Medical, Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable
PEG ratio (TTM/FY)
Modular Medical, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Price-to-book ratio (FY)
Modular Medical, Inc. has a price-to-book ratio of 0.72x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Price-to-sales ratio (TTM)
Modular Medical, Inc. has a price-to-sales ratio of 999.00x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue
Profit margin
Current Ratio
Capital Returns
-131.58%
Return on equity
ROIC: -107.75%
Valuation History
-
Price to Earnings
EV/EBITDA: -
Cash flow
Profit margin
-22.68%
Cash flow
-26.30%
Fair Value
Market $1.87
—
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.